Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Transcription co-factors SKI and SKIL protein partners WP4533,0.0010386797328595285,29.83277027027027,204.94531018835437,"['LATS1', 'MERTK', 'STK3']",0.2586312534820226,0,0,3
2,DNA IR-double strand breaks and cellular response via ATM WP3959,0.0033992315988640065,5.874349739895958,33.39101329295933,"['LATS1', 'ATF2', 'PCNA', 'TRIM28', 'STK3']",0.30191488373391157,0,0,5
3,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.0036375287196856814,7.971525423728814,44.77167995327098,"['LATS1', 'ITGB5', 'NF2', 'STK3']",0.30191488373391157,0,0,4
4,Metastatic brain tumor WP2249,0.0067584134919038055,39.64983164983165,198.1289045530169,"['CDK6', 'E2F3']",0.3758677590944739,0,0,2
5,Hippo-Yap signaling pathway WP4537,0.00754754536334285,9.9375,48.559920554837355,"['LATS1', 'NF2', 'STK3']",0.3758677590944739,0,0,3
6,Oxidative Damage WP3941,0.02226236758398822,5.958445945945946,22.67103821246596,"['PCNA', 'BAD', 'TRAF3']",0.7782257245794904,0,0,3
7,Retinoblastoma gene in cancer WP2446,0.03898110984443204,3.458216654384672,11.220799889038368,"['PCNA', 'CDK6', 'E2F3', 'SAP30']",0.7782257245794904,0,0,4
8,Kennedy pathway from sphingolipids WP3933,0.04159235208322288,7.924579124579124,25.198885543133287,"['CHKA', 'ETNK1']",0.7782257245794904,0,0,2
9,Apoptosis WP254,0.04895908944226905,3.1804745762711866,9.594761047412568,"['CASP6', 'TRAF3', 'BAD', 'IRF2']",0.7782257245794904,0,0,4
10,Hematopoietic Stem Cell Differentiation WP2849,0.053717594330611934,6.602693602693603,19.30637308760746,"['PIM1', 'ACVR1B']",0.7782257245794904,0,0,2
11,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.053717594330611934,6.602693602693603,19.30637308760746,"['LATS1', 'STK3']",0.7782257245794904,0,0,2
12,Autophagy WP4923,0.0810361353614143,4.950336700336701,12.439503616516932,"['DEPTOR', 'ATG7']",0.7782257245794904,0,0,2
13,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.0810361353614143,4.950336700336701,12.439503616516932,"['IDH1', 'OGDH']",0.7782257245794904,0,0,2
14,Globo Sphingolipid Metabolism WP1424,0.0810361353614143,4.950336700336701,12.439503616516932,"['ST6GAL1', 'ST6GAL2']",0.7782257245794904,0,0,2
15,B Cell Receptor Signaling Pathway WP23,0.08643041924509816,2.5622744669218154,6.27351275205343,"['ATF2', 'CAMK2A', 'PIP5K1A', 'E2F3']",0.7782257245794904,0,0,4
16,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.09431103996112834,19.758389261744966,46.65265957716514,['TRAF3'],0.7782257245794904,0,0,1
17,Valproic acid pathway WP3871,0.09431103996112834,19.758389261744966,46.65265957716514,['IVD'],0.7782257245794904,0,0,1
18,Neural Crest Differentiation WP2064,0.10702714484857247,2.832046332046332,6.328696868389327,"['LHX2', 'MBP', 'HDAC8']",0.7782257245794904,0,0,3
19,G1 to S cell cycle control WP45,0.11749204606388493,2.7028562653562656,5.78785489282266,"['PCNA', 'CDK6', 'E2F3']",0.7782257245794904,0,0,3
20,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.12787202842385584,3.598408325681053,7.400937418374719,"['IFITM3', 'ATF2']",0.7782257245794904,0,0,2
21,Non-small cell lung cancer WP4255,0.12832062020093574,2.584900117508813,5.30737715367821,"['CDK6', 'BAD', 'E2F3']",0.7782257245794904,0,0,3
22,Hippo-Merlin Signaling Dysregulation WP4541,0.13424536711872845,2.144571690334402,4.306484506479928,"['LATS1', 'ITGB5', 'NF2', 'STK3']",0.7782257245794904,0,0,4
23,Cell Differentiation - Index WP2029,0.13808740477557824,9.87751677852349,19.556183600825296,['LEFTY1'],0.7782257245794904,0,0,1
24,Cytosine methylation WP3585,0.13808740477557824,9.87751677852349,19.556183600825296,['IDH1'],0.7782257245794904,0,0,1
25,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.13808740477557824,9.87751677852349,19.556183600825296,['EPHX2'],0.7782257245794904,0,0,1
26,NAD+ metabolism WP3644,0.13808740477557824,9.87751677852349,19.556183600825296,['NAMPT'],0.7782257245794904,0,0,1
27,Ectoderm Differentiation WP2858,0.13955863877329042,1.909013605442177,3.7593640177282484,"['GREB1', 'PIM1', 'ROR2', 'NR2F2', 'NF2']",0.7782257245794904,0,0,5
28,Ethanol effects on histone modifications WP3996,0.14462706314330087,3.297979797979798,6.376963276518565,"['ATF2', 'HDAC8']",0.7782257245794904,0,0,2
29,Monoamine GPCRs WP58,0.14462706314330087,3.297979797979798,6.376963276518565,"['HTR2C', 'HTR5A']",0.7782257245794904,0,0,2
30,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.15096945216811558,2.3772972972972974,4.494703143542142,"['PFKFB2', 'ATF2', 'BAD']",0.7782257245794904,0,0,3
31,Mesodermal commitment pathway WP2857,0.15216140339668421,2.0338983050847457,3.829451099111718,"['LATS1', 'LEFTY1', 'TRIM28', 'ACVR2A']",0.7782257245794904,0,0,4
32,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.1618029482229056,3.0437710437710437,5.543851690308817,"['DEPTOR', 'ATG7']",0.7782257245794904,0,0,2
33,Parkinson's disease pathway WP2371,0.1618029482229056,3.0437710437710437,5.543851690308817,"['CASP6', 'UBE2J1']",0.7782257245794904,0,0,2
34,Prader-Willi and Angelman Syndrome WP3998,0.1618029482229056,3.0437710437710437,5.543851690308817,"['CDK6', 'HTR2C']",0.7782257245794904,0,0,2
35,Apoptosis Modulation and Signaling WP1772,0.17477461168384614,2.2004504504504503,3.8381534522963614,"['CASP6', 'TRAF3', 'BAD']",0.7782257245794904,0,0,3
36,Melanoma WP4685,0.17477461168384614,2.2004504504504503,3.8381534522963614,"['CDK6', 'BAD', 'E2F3']",0.7782257245794904,0,0,3
37,One-carbon metabolism and related pathways WP3940,0.1793202775800383,2.825877825877826,4.8565022337443216,"['CHKA', 'ETNK1']",0.7782257245794904,0,0,2
38,Acetylcholine Synthesis WP528,0.17975458525938473,6.583892617449664,11.299031415537762,['CHKA'],0.7782257245794904,0,0,1
39,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.17975458525938473,6.583892617449664,11.299031415537762,['EPHX2'],0.7782257245794904,0,0,1
40,Caloric restriction and aging WP4191,0.17975458525938473,6.583892617449664,11.299031415537762,['NAMPT'],0.7782257245794904,0,0,1
41,Disorders of the Krebs cycle WP4236,0.17975458525938473,6.583892617449664,11.299031415537762,['DHTKD1'],0.7782257245794904,0,0,1
42,Glutathione metabolism WP100,0.17975458525938473,6.583892617449664,11.299031415537762,['IDH1'],0.7782257245794904,0,0,1
43,Hedgehog Signaling Pathway Netpath WP47,0.17975458525938473,6.583892617449664,11.299031415537762,['KIF7'],0.7782257245794904,0,0,1
44,ErbB signaling pathway WP673,0.18704916474459898,2.121500965250965,3.556449815060558,"['BTC', 'BAD', 'CAMK2A']",0.7782257245794904,0,0,3
45,Wnt Signaling Pathway WP363,0.19710629046067515,2.637037037037037,4.282580188835937,"['CDK6', 'ROR2']",0.7782257245794904,0,0,2
46,Energy Metabolism WP1541,0.19710629046067515,2.637037037037037,4.282580188835937,"['ATF2', 'PPARGC1B']",0.7782257245794904,0,0,2
47,NO/cGMP/PKG mediated Neuroprotection WP4008,0.19710629046067515,2.637037037037037,4.282580188835937,"['BAD', 'CAMK2A']",0.7782257245794904,0,0,2
48,Amino Acid metabolism WP3925,0.19953943904689891,2.047996272134203,3.3008444189922765,"['LARS2', 'IDH1', 'OGDH']",0.7782257245794904,0,0,3
49,MECP2 and Associated Rett Syndrome WP3584,0.19953943904689891,2.047996272134203,3.3008444189922765,"['RBFOX1', 'CAMK2A', 'MBP']",0.7782257245794904,0,0,3
50,Small cell lung cancer WP4658,0.21222178878311432,1.9793918918918918,3.06830164517821,"['CDK6', 'TRAF3', 'E2F3']",0.7782257245794904,0,0,3
51,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.21509441816661784,2.471801346801347,3.7983632270357774,"['ATF2', 'CAMK2A']",0.7782257245794904,0,0,2
52,Serotonin and anxiety-related events WP3944,0.21941387490653155,4.9370805369127515,7.488541506524273,['HTR2C'],0.7782257245794904,0,0,1
53,Apoptosis Modulation by HSP70 WP384,0.21941387490653155,4.9370805369127515,7.488541506524273,['CASP6'],0.7782257245794904,0,0,1
54,Autosomal recessive Osteopetrosis pathways WP4788,0.21941387490653155,4.9370805369127515,7.488541506524273,['OSTM1'],0.7782257245794904,0,0,1
55,Glial Cell Differentiation WP2276,0.21941387490653155,4.9370805369127515,7.488541506524273,['MBP'],0.7782257245794904,0,0,1
56,Pancreatic adenocarcinoma pathway WP4263,0.22507309971220382,1.9152136006974716,2.856215579437804,"['CDK6', 'BAD', 'E2F3']",0.7782257245794904,0,0,3
57,Disruption of postsynaptic signaling by CNV WP4875,0.23322385872208198,2.3260051495345615,3.386097161081668,"['NLGN2', 'CAMK2A']",0.7782257245794904,0,0,2
58,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.23322385872208198,2.3260051495345615,3.386097161081668,"['DEPTOR', 'IGFBP5']",0.7782257245794904,0,0,2
59,Myometrial relaxation and contraction pathways WP289,0.23977542701940227,1.5478847789115646,2.2104607506075493,"['ATF2', 'RGS17', 'IGFBP5', 'GRK4', 'CAMK2A']",0.7782257245794904,0,0,5
60,ATM Signaling Network in Development and Disease  WP3878,0.2514391781488167,2.196408529741863,3.0322609219792604,"['ATF2', 'TRIM28']",0.7782257245794904,0,0,2
61,IL-4 signaling pathway WP395,0.2514391781488167,2.196408529741863,3.0322609219792604,"['ATF2', 'BAD']",0.7782257245794904,0,0,2
62,Thiamine metabolic pathways WP4297,0.25716172061383225,3.948993288590604,5.362930844599952,['OGDH'],0.7782257245794904,0,0,1
63,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.25716172061383225,3.948993288590604,5.362930844599952,['RPH3AL'],0.7782257245794904,0,0,1
64,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.25716172061383225,3.948993288590604,5.362930844599952,['ATG7'],0.7782257245794904,0,0,1
65,"NAD metabolism, sirtuins and aging WP3630",0.25716172061383225,3.948993288590604,5.362930844599952,['NAMPT'],0.7782257245794904,0,0,1
66,NAD+ biosynthetic pathways WP3645,0.25716172061383225,3.948993288590604,5.362930844599952,['NAMPT'],0.7782257245794904,0,0,1
67,Nanoparticle triggered autophagic cell death WP2509,0.25716172061383225,3.948993288590604,5.362930844599952,['ATG7'],0.7782257245794904,0,0,1
68,Purinergic signaling WP4900,0.25716172061383225,3.948993288590604,5.362930844599952,['PANX1'],0.7782257245794904,0,0,1
69,Senescence and Autophagy in Cancer WP615,0.2777275316901543,1.6951737451737452,2.1717120849226133,"['PCNA', 'IGFBP5', 'ATG7']",0.7782257245794904,0,0,3
70,"GPCRs, Class A Rhodopsin-like WP455",0.2777275316901543,1.6951737451737452,2.1717120849226133,"['MC1R', 'HTR2C', 'HTR5A']",0.7782257245794904,0,0,3
71,Fragile X Syndrome  WP4549,0.2851741871014662,1.5220338983050847,1.909627596834798,"['DEPTOR', 'CAMK2A', 'AKAP5', 'DLGAP3']",0.7782257245794904,0,0,4
72,Hepatitis B infection WP4666,0.2851741871014662,1.5220338983050847,1.909627596834798,"['ATF2', 'PCNA', 'TRAF3', 'BAD']",0.7782257245794904,0,0,4
73,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.28793033734993495,1.9760942760942761,2.4603099207161256,"['CYLD', 'TRAF3']",0.7782257245794904,0,0,2
74,Pathways Regulating Hippo Signaling WP4540,0.2910994156337832,1.647804054054054,2.033539222973052,"['LATS1', 'NF2', 'STK3']",0.7782257245794904,0,0,3
75,Biomarkers for pyrimidine metabolism disorders WP4584,0.2930899523353058,3.290268456375839,4.0380665641937945,['PUS1'],0.7782257245794904,0,0,1
76,Cell Differentiation - Index expanded WP2023,0.2930899523353058,3.290268456375839,4.0380665641937945,['LEFTY1'],0.7782257245794904,0,0,1
77,Tryptophan catabolism leading to NAD+ production WP4210,0.2930899523353058,3.290268456375839,4.0380665641937945,['NAMPT'],0.7782257245794904,0,0,1
78,Type II diabetes mellitus WP1584,0.2930899523353058,3.290268456375839,4.0380665641937945,['PHKA2'],0.7782257245794904,0,0,1
79,Differentiation of white and brown adipocyte WP2895,0.2930899523353058,3.290268456375839,4.0380665641937945,['PPARGC1B'],0.7782257245794904,0,0,1
80,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2930899523353058,3.290268456375839,4.0380665641937945,['BAD'],0.7782257245794904,0,0,1
81,miRNAs involved in DNA damage response WP1545,0.2930899523353058,3.290268456375839,4.0380665641937945,['CDK6'],0.7782257245794904,0,0,1
82,Mitochondrial Gene Expression WP391,0.2930899523353058,3.290268456375839,4.0380665641937945,['PPARGC1B'],0.7782257245794904,0,0,1
83,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.2930899523353058,3.290268456375839,4.0380665641937945,['NAMPT'],0.7782257245794904,0,0,1
84,Nanomaterial induced apoptosis WP2507,0.2930899523353058,3.290268456375839,4.0380665641937945,['CASP6'],0.7782257245794904,0,0,1
85,SARS coronavirus and innate immunity WP4912,0.2930899523353058,3.290268456375839,4.0380665641937945,['TRAF3'],0.7782257245794904,0,0,1
86,Regulation of toll-like receptor signaling pathway WP1449,0.30451561554578904,1.6029948867786705,1.906013675849666,"['CYLD', 'CUEDC2', 'TRAF3']",0.7782257245794904,0,0,3
87,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.3061188991643496,1.8816738816738816,2.2274910935829206,"['ATF2', 'MBP']",0.7782257245794904,0,0,2
88,Synaptic Vesicle Pathway WP2267,0.3061188991643496,1.8816738816738816,2.2274910935829206,"['UNC13B', 'UNC13C']",0.7782257245794904,0,0,2
89,3q29 copy number variation syndrome WP4906,0.324218147798147,1.7958371594735232,2.0227208809787935,"['NF2', 'WDR34']",0.7782257245794904,0,0,2
90,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.324218147798147,1.7958371594735232,2.0227208809787935,"['CDK6', 'ROR2']",0.7782257245794904,0,0,2
91,Serotonin and anxiety WP3947,0.3272860027796969,2.819750719079578,3.1494384097289627,['HTR2C'],0.7782257245794904,0,0,1
92,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3272860027796969,2.819750719079578,3.1494384097289627,['TRAF3'],0.7782257245794904,0,0,1
93,Zinc homeostasis WP3529,0.3272860027796969,2.819750719079578,3.1494384097289627,['SLC39A11'],0.7782257245794904,0,0,1
94,DNA Mismatch Repair WP531,0.3272860027796969,2.819750719079578,3.1494384097289627,['PCNA'],0.7782257245794904,0,0,1
95,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3272860027796969,2.819750719079578,3.1494384097289627,['SESN3'],0.7782257245794904,0,0,1
96,miRNAs involvement in the immune response in sepsis WP4329,0.3272860027796969,2.819750719079578,3.1494384097289627,['TRAF3'],0.7782257245794904,0,0,1
97,Cell cycle WP179,0.33140924831360874,1.5202702702702702,1.6789884135488424,"['CDK6', 'PCNA', 'E2F3']",0.7782257245794904,0,0,3
98,Metapathway biotransformation Phase I and II WP702,0.33140924831360874,1.5202702702702702,1.6789884135488424,"['EPHX2', 'NDST3', 'KCNAB3']",0.7782257245794904,0,0,3
99,Regulatory circuits of the STAT3 signaling pathway WP4538,0.3421943280103168,1.7174645000731956,1.841768556982861,"['DEPTOR', 'TRIM28']",0.7782257245794904,0,0,2
100,16p11.2 distal deletion syndrome WP4950,0.3598331172468631,2.4668624161073827,2.5214168766842393,['RAB4A'],0.7782257245794904,0,0,1
101,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3598331172468631,2.4668624161073827,2.5214168766842393,['CASP6'],0.7782257245794904,0,0,1
102,Gastric Cancer Network 1 WP2361,0.3598331172468631,2.4668624161073827,2.5214168766842393,['SMOC2'],0.7782257245794904,0,0,1
103,Hedgehog Signaling Pathway WP4249,0.3598331172468631,2.4668624161073827,2.5214168766842393,['KIF7'],0.7782257245794904,0,0,1
104,IL-7 signaling pathway WP205,0.3598331172468631,2.4668624161073827,2.5214168766842393,['BAD'],0.7782257245794904,0,0,1
105,Immune response to tuberculosis WP4197,0.3598331172468631,2.4668624161073827,2.5214168766842393,['PTPN2'],0.7782257245794904,0,0,1
106,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.3598331172468631,2.4668624161073827,2.5214168766842393,['B4GALT2'],0.7782257245794904,0,0,1
107,Monoamine Transport WP727,0.3598331172468631,2.4668624161073827,2.5214168766842393,['UNC13B'],0.7782257245794904,0,0,1
108,MTHFR deficiency WP4288,0.3598331172468631,2.4668624161073827,2.5214168766842393,['CHKA'],0.7782257245794904,0,0,1
109,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.3598331172468631,2.4668624161073827,2.5214168766842393,['MBP'],0.7782257245794904,0,0,1
110,Prostaglandin Synthesis and Regulation WP98,0.3598331172468631,2.4668624161073827,2.5214168766842393,['PPARGC1B'],0.7782257245794904,0,0,1
111,Ras signaling WP4223,0.38512310905650715,1.2954709641567101,1.236128330811959,"['RASA4', 'BAD', 'RASGRF2', 'KSR2']",0.7782257245794904,0,0,4
112,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3908105533074715,2.192393736017897,2.0598248494692886,['HTR2C'],0.7782257245794904,0,0,1
113,Toll-like Receptor Signaling related to MyD88 WP3858,0.3908105533074715,2.192393736017897,2.0598248494692886,['TRAF3'],0.7782257245794904,0,0,1
114,Type II interferon signaling (IFNG) WP619,0.3908105533074715,2.192393736017897,2.0598248494692886,['IRF2'],0.7782257245794904,0,0,1
115,FOXA2 pathway WP5066,0.3908105533074715,2.192393736017897,2.0598248494692886,['PPARGC1B'],0.7782257245794904,0,0,1
116,Imatinib and Chronic Myeloid Leukemia WP3640,0.3908105533074715,2.192393736017897,2.0598248494692886,['PIM1'],0.7782257245794904,0,0,1
117,miRNA targets in ECM and membrane receptors WP2911,0.3908105533074715,2.192393736017897,2.0598248494692886,['ITGB5'],0.7782257245794904,0,0,1
118,Wnt signaling WP428,0.4123087873475759,1.4620276842499065,1.2953312739131932,"['CAMK2A', 'ROR2']",0.7782257245794904,0,0,2
119,Calcium Regulation in the Cardiac Cell WP536,0.4183417420947996,1.2341101694915255,1.0754734716583503,"['SLC8A3', 'RGS17', 'GRK4', 'CAMK2A']",0.7782257245794904,0,0,4
120,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4202937712559521,1.9728187919463087,1.710042005655176,['OGDH'],0.7782257245794904,0,0,1
121,TLR4 Signaling and Tolerance WP3851,0.4202937712559521,1.9728187919463087,1.710042005655176,['TRAF3'],0.7782257245794904,0,0,1
122,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4202937712559521,1.9728187919463087,1.710042005655176,['TRAF3'],0.7782257245794904,0,0,1
123,Tryptophan metabolism WP465,0.4202937712559521,1.9728187919463087,1.710042005655176,['OGDH'],0.7782257245794904,0,0,1
124,GDNF/RET signaling axis WP4830,0.4202937712559521,1.9728187919463087,1.710042005655176,['FAT4'],0.7782257245794904,0,0,1
125,Glycerolipids and Glycerophospholipids WP4722,0.4202937712559521,1.9728187919463087,1.710042005655176,['ETNK1'],0.7782257245794904,0,0,1
126,Glycerophospholipid Biosynthetic Pathway WP2533,0.4202937712559521,1.9728187919463087,1.710042005655176,['PIP5K1A'],0.7782257245794904,0,0,1
127,Melatonin metabolism and effects WP3298,0.4202937712559521,1.9728187919463087,1.710042005655176,['CAMK2A'],0.7782257245794904,0,0,1
128,Phosphoinositides metabolism WP4971,0.4202937712559521,1.9728187919463087,1.710042005655176,['PIP5K1A'],0.7782257245794904,0,0,1
129,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4202937712559521,1.9728187919463087,1.710042005655176,['BAD'],0.7782257245794904,0,0,1
130,AMP-activated protein kinase (AMPK) signaling WP1403,0.4292755085793216,1.4095719095719095,1.1920134432193528,"['CPT1B', 'PPARGC1B']",0.7782257245794904,0,0,2
131,Corticotropin-releasing hormone signaling pathway WP2355,0.4292755085793216,1.4095719095719095,1.1920134432193528,"['TRIM28', 'CAMK2A']",0.7782257245794904,0,0,2
132,Head and Neck Squamous Cell Carcinoma WP4674,0.4292755085793216,1.4095719095719095,1.1920134432193528,"['CDK6', 'TRAF3']",0.7782257245794904,0,0,2
133,Ciliopathies WP4803,0.4402647628976291,1.196302003081664,0.9814210400061303,"['XPNPEP3', 'ALMS1', 'KIF7', 'WDR34']",0.7782257245794904,0,0,4
134,TNF-alpha signaling pathway WP231,0.44598076754799365,1.360733774526878,1.0987645598262918,"['BAD', 'KSR2']",0.7782257245794904,0,0,2
135,DNA IR-damage and cellular response via ATR WP4016,0.44598076754799365,1.360733774526878,1.0987645598262918,"['PCNA', 'TRIM28']",0.7782257245794904,0,0,2
136,7-oxo-C and 7beta-HC pathways WP5064,0.4483546152990864,1.7931665649786455,1.4384258717199443,['EPHX2'],0.7782257245794904,0,0,1
137,The influence of laminopathies on Wnt signaling WP4844,0.4483546152990864,1.7931665649786455,1.4384258717199443,['CDK6'],0.7782257245794904,0,0,1
138,White fat cell differentiation WP4149,0.4483546152990864,1.7931665649786455,1.4384258717199443,['NR2F2'],0.7782257245794904,0,0,1
139,Fatty acid beta-oxidation WP143,0.4483546152990864,1.7931665649786455,1.4384258717199443,['CPT1B'],0.7782257245794904,0,0,1
140,Glycosylation and related congenital defects WP4521,0.4483546152990864,1.7931665649786455,1.4384258717199443,['MAGT1'],0.7782257245794904,0,0,1
141,IL17 signaling pathway WP2112,0.4483546152990864,1.7931665649786455,1.4384258717199443,['TRAF3'],0.7782257245794904,0,0,1
142,SARS-CoV-2 mitochondrial interactions WP5038,0.4483546152990864,1.7931665649786455,1.4384258717199443,['TRAF3'],0.7782257245794904,0,0,1
143,Integrated breast cancer pathway WP1984,0.45040747111908225,1.2333192567567568,0.9836986637665701,"['BAD', 'DCAKD', 'DHTKD1']",0.7782257245794904,0,0,3
144,Amyotrophic lateral sclerosis (ALS) WP2447,0.47506148649029134,1.6434563758389262,1.2232427211433003,['BAD'],0.7782257245794904,0,0,1
145,Cardiac Progenitor Differentiation WP2406,0.47506148649029134,1.6434563758389262,1.2232427211433003,['ROR2'],0.7782257245794904,0,0,1
146,Tumor suppressor activity of SMARCB1 WP4204,0.47506148649029134,1.6434563758389262,1.2232427211433003,['CDK6'],0.7782257245794904,0,0,1
147,Differentiation Pathway WP2848,0.47506148649029134,1.6434563758389262,1.2232427211433003,['LEFTY1'],0.7782257245794904,0,0,1
148,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.47506148649029134,1.6434563758389262,1.2232427211433003,['TRAF3'],0.7782257245794904,0,0,1
149,Integrated Cancer Pathway WP1971,0.47506148649029134,1.6434563758389262,1.2232427211433003,['BAD'],0.7782257245794904,0,0,1
150,Intraflagellar transport proteins binding to dynein WP4532,0.47506148649029134,1.6434563758389262,1.2232427211433003,['WDR34'],0.7782257245794904,0,0,1
151,Nuclear receptors WP170,0.47506148649029134,1.6434563758389262,1.2232427211433003,['NR2F2'],0.7782257245794904,0,0,1
152,Peptide GPCRs WP24,0.47506148649029134,1.6434563758389262,1.2232427211433003,['MC1R'],0.7782257245794904,0,0,1
153,16p11.2 proximal deletion syndrome WP4949,0.4943937466663425,1.23253367003367,0.8682250916340692,"['UNC13B', 'PCNA']",0.788730362389572,0,0,2
154,Splicing factor NOVA regulated synaptic proteins WP4148,0.5004795070584432,1.516778523489933,1.0498968421258168,['NTNG1'],0.788730362389572,0,0,1
155,DNA Replication WP466,0.5004795070584432,1.516778523489933,1.0498968421258168,['PCNA'],0.788730362389572,0,0,1
156,MAPK Cascade WP422,0.5004795070584432,1.516778523489933,1.0498968421258168,['MBP'],0.788730362389572,0,0,1
157,miRNA regulation of prostate cancer signaling pathways WP3981,0.5004795070584432,1.516778523489933,1.0498968421258168,['BAD'],0.788730362389572,0,0,1
158,Oxysterols derived from cholesterol WP4545,0.5004795070584432,1.516778523489933,1.0498968421258168,['EPHX2'],0.788730362389572,0,0,1
159,ATM Signaling Pathway WP2516,0.5246706769843701,1.4081975071907957,0.9082655582450748,['ATF2'],0.8022106578301633,0,0,1
160,Type 2 papillary renal cell carcinoma WP4241,0.5246706769843701,1.4081975071907957,0.9082655582450748,['COL21A1'],0.8022106578301633,0,0,1
161,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5246706769843701,1.4081975071907957,0.9082655582450748,['RAB4A'],0.8022106578301633,0,0,1
162,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5246706769843701,1.4081975071907957,0.9082655582450748,['ATF2'],0.8022106578301633,0,0,1
163,Thermogenesis WP4321,0.5251481743722085,1.1596355714002773,0.7468920711178766,"['ATF2', 'CPT1B']",0.8022106578301633,0,0,2
164,G Protein Signaling Pathways WP35,0.5400469824435749,1.1263107263107264,0.6939190683698597,"['AKAP5', 'PDE7B']",0.8022106578301633,0,0,2
165,Copper homeostasis WP3286,0.5476940234181839,1.3140939597315435,0.7911351555834384,['COMMD1'],0.8022106578301633,0,0,1
166,Glycogen Synthesis and Degradation WP500,0.5476940234181839,1.3140939597315435,0.7911351555834384,['PHKA2'],0.8022106578301633,0,0,1
167,Histone Modifications WP2369,0.5476940234181839,1.3140939597315435,0.7911351555834384,['KMT5A'],0.8022106578301633,0,0,1
168,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5476940234181839,1.3140939597315435,0.7911351555834384,['HDAC8'],0.8022106578301633,0,0,1
169,p38 MAPK Signaling Pathway WP400,0.5476940234181839,1.3140939597315435,0.7911351555834384,['ATF2'],0.8022106578301633,0,0,1
170,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5476940234181839,1.3140939597315435,0.7911351555834384,['TRAF3'],0.8022106578301633,0,0,1
171,Ebola Virus Pathway on Host WP4217,0.5688646383643152,1.065065065065065,0.6008168009619776,"['DAB2IP', 'MERTK']",0.810467599497251,0,0,2
172,Base Excision Repair WP4752,0.5696057426185499,1.231753355704698,0.6932441372135978,['PCNA'],0.810467599497251,0,0,1
173,TGF-beta Receptor Signaling WP560,0.5696057426185499,1.231753355704698,0.6932441372135978,['LEFTY1'],0.810467599497251,0,0,1
174,IL-3 signaling pathway WP286,0.5696057426185499,1.231753355704698,0.6932441372135978,['BAD'],0.810467599497251,0,0,1
175,Photodynamic therapy-induced unfolded protein response WP3613,0.5696057426185499,1.231753355704698,0.6932441372135978,['PDIA6'],0.810467599497251,0,0,1
176,Aryl Hydrocarbon Receptor Netpath WP2586,0.5904593353615478,1.1590998815633635,0.6106770006892934,['PLAGL1'],0.8138635337503057,0,0,1
177,Cytosolic DNA-sensing pathway WP4655,0.5904593353615478,1.1590998815633635,0.6106770006892934,['CYLD'],0.8138635337503057,0,0,1
178,IL-6 signaling pathway WP364,0.5904593353615478,1.1590998815633635,0.6106770006892934,['BAD'],0.8138635337503057,0,0,1
179,IL-18 signaling pathway WP4754,0.5938219256417061,0.9722536095417451,0.5067150459957451,"['LARS2', 'PHF20', 'BAD', 'TSHZ1']",0.8138635337503057,0,0,4
180,Breast cancer pathway WP4262,0.5963582251030546,1.0101010101010102,0.5221350945895572,"['CDK6', 'E2F3']",0.8138635337503057,0,0,2
181,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6103057357389683,1.0945190156599554,0.5404682813874149,['LEFTY1'],0.8138635337503057,0,0,1
182,Development of ureteric collection system WP5053,0.6103057357389683,1.0945190156599554,0.5404682813874149,['FAT4'],0.8138635337503057,0,0,1
183,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6103057357389683,1.0945190156599554,0.5404682813874149,['ROR2'],0.8138635337503057,0,0,1
184,Nephrotic syndrome WP4758,0.6103057357389683,1.0945190156599554,0.5404682813874149,['E2F3'],0.8138635337503057,0,0,1
185,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6160897552847604,0.9419511492478959,0.45624592602640435,"['ATF2', 'INPP4B', 'RAB4A', 'RCN1', 'ITGB5', 'PTPN9', 'WASF1', 'PDIA6']",0.8138635337503057,0,0,8
186,Common Pathways Underlying Drug Addiction WP2636,0.6291934339258816,1.0367361356411162,0.48033700282860814,['CAMK2A'],0.8138635337503057,0,0,1
187,Ferroptosis WP4313,0.6291934339258816,1.0367361356411162,0.48033700282860814,['ATG7'],0.8138635337503057,0,0,1
188,Kit receptor signaling pathway WP304,0.6291934339258816,1.0367361356411162,0.48033700282860814,['BAD'],0.8138635337503057,0,0,1
189,Nucleotide Excision Repair WP4753,0.6291934339258816,1.0367361356411162,0.48033700282860814,['PCNA'],0.8138635337503057,0,0,1
190,PPAR signaling pathway WP3942,0.6291934339258816,1.0367361356411162,0.48033700282860814,['CPT1B'],0.8138635337503057,0,0,1
191,Vitamin D Receptor Pathway WP2877,0.6351036244600033,0.9374699374699375,0.4255805137976155,"['IGFBP5', 'CLEC16A']",0.8138635337503057,0,0,2
192,DNA Repair Pathways Full Network WP4946,0.6351036244600033,0.9374699374699375,0.4255805137976155,"['PCNA', 'FANCL']",0.8138635337503057,0,0,2
193,Gastrin signaling pathway WP4659,0.6351036244600033,0.9374699374699375,0.4255805137976155,"['ATF2', 'BAD']",0.8138635337503057,0,0,2
194,Notch Signaling Pathway Netpath WP61,0.6471685931026527,0.984731543624161,0.4285043967598003,['SAP30'],0.8138635337503057,0,0,1
195,Phosphodiesterases in neuronal function WP4222,0.6471685931026527,0.984731543624161,0.4285043967598003,['PDE7B'],0.8138635337503057,0,0,1
196,Proximal tubule transport WP4917,0.6471685931026527,0.984731543624161,0.4285043967598003,['SLC13A3'],0.8138635337503057,0,0,1
197,RANKL/RANK signaling pathway WP2018,0.6471685931026527,0.984731543624161,0.4285043967598003,['TRAF3'],0.8138635337503057,0,0,1
198,Rett syndrome causing genes WP4312,0.6471685931026527,0.984731543624161,0.4285043967598003,['HDAC8'],0.8138635337503057,0,0,1
199,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6642751607273318,0.9376797698945349,0.3835661770785021,['PIM1'],0.8253138954843141,0,0,1
200,Regulation of Actin Cytoskeleton WP51,0.670884580213189,0.8745230078563412,0.34907300204915753,"['PIP5K1A', 'WASF1']",0.8253138954843141,0,0,2
201,DNA damage response WP707,0.680554974583063,0.8949054301403294,0.3444013788527857,['CDK6'],0.8253138954843141,0,0,1
202,Endometrial cancer WP4155,0.680554974583063,0.8949054301403294,0.3444013788527857,['BAD'],0.8253138954843141,0,0,1
203,Eukaryotic Transcription Initiation WP405,0.680554974583063,0.8949054301403294,0.3444013788527857,['POLR1B'],0.8253138954843141,0,0,1
204,IL-1 signaling pathway WP195,0.680554974583063,0.8949054301403294,0.3444013788527857,['ATF2'],0.8253138954843141,0,0,1
205,MET in type 1 papillary renal cell carcinoma WP4205,0.680554974583063,0.8949054301403294,0.3444013788527857,['BAD'],0.8253138954843141,0,0,1
206,Ciliary landscape WP4352,0.6891229413448995,0.8543846720707443,0.3181178204695822,"['XPNPEP3', 'CAMK2A', 'TNKS1BP1', 'WDR34']",0.8253138954843141,0,0,4
207,miRNA regulation of DNA damage response WP1530,0.6960478636614698,0.8558505981908374,0.31010621100331687,['CDK6'],0.8253138954843141,0,0,1
208,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6960478636614698,0.8558505981908374,0.31010621100331687,['CAMK2A'],0.8253138954843141,0,0,1
209,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6960478636614698,0.8558505981908374,0.31010621100331687,['PCNA'],0.8253138954843141,0,0,1
210,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6960478636614698,0.8558505981908374,0.31010621100331687,['BAD'],0.8253138954843141,0,0,1
211,7q11.23 copy number variation syndrome WP4932,0.7037783816236908,0.8194444444444444,0.28786409030005966,"['PCNA', 'OGDH']",0.8270427305828887,0,0,2
212,AGE/RAGE pathway WP2324,0.7107917443563783,0.8200503355704698,0.27994533717194037,['ATF2'],0.8270427305828887,0,0,1
213,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7107917443563783,0.8200503355704698,0.27994533717194037,['BAD'],0.8270427305828887,0,0,1
214,Mitochondrial CIV Assembly WP4922,0.7107917443563783,0.8200503355704698,0.27994533717194037,['SMIM20'],0.8270427305828887,0,0,1
215,EGF/EGFR signaling pathway WP437,0.7241580369316776,0.7863973063973064,0.2538062920089047,"['PCNA', 'CAMK2A']",0.831302423751025,0,0,2
216,Acute viral myocarditis WP4298,0.7248227119656471,0.7871140939597315,0.2533155035929006,['CASP6'],0.831302423751025,0,0,1
217,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7248227119656471,0.7871140939597315,0.2533155035929006,['ITGB5'],0.831302423751025,0,0,1
218,PI3K-Akt signaling pathway WP4172,0.733980238790901,0.801245243860256,0.24780365920685996,"['ATF2', 'CDK6', 'ITGB5', 'BAD']",0.831302423751025,0,0,4
219,T-cell receptor (TCR) signaling pathway WP69,0.738175127915885,0.7567114093959731,0.22971804699182857,['ATF2'],0.831302423751025,0,0,1
220,Toll-like Receptor Signaling Pathway WP75,0.738175127915885,0.7567114093959731,0.22971804699182857,['TRAF3'],0.831302423751025,0,0,1
221,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.743343623140779,0.7558922558922558,0.22419526997512063,"['BAD', 'CAMK2A']",0.831302423751025,0,0,2
222,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7508817028580314,0.7285607755406414,0.20873787804796537,['SLC38A2'],0.831302423751025,0,0,1
223,Endochondral Ossification WP474,0.7508817028580314,0.7285607755406414,0.20873787804796537,['SLC38A2'],0.831302423751025,0,0,1
224,Male infertility WP4673,0.7508817028580314,0.7285607755406414,0.20873787804796537,['TEX15'],0.831302423751025,0,0,1
225,Insulin Signaling WP481,0.7525020130730629,0.7415030811257226,0.21084759284890053,"['CYTH3', 'RAB4A']",0.831302423751025,0,0,2
226,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7545154528824565,0.7770431280416177,0.21887713534660277,"['PFKFB2', 'ATF2', 'ITGB5', 'BAD']",0.831302423751025,0,0,4
227,MAPK Signaling Pathway WP382,0.7654564347975953,0.7453814574067739,0.199227774402804,"['ATF2', 'RASGRF2', 'STK3']",0.839641639932164,0,0,3
228,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7854303578590188,0.6553691275167786,0.15828703554031162,['BAD'],0.8540268956632999,0,0,1
229,Glioblastoma signaling pathways WP2261,0.7854303578590188,0.6553691275167786,0.15828703554031162,['CDK6'],0.8540268956632999,0,0,1
230,Alzheimer's disease WP2059,0.7958503459898717,0.6341199393808183,0.14479755849482018,['BAD'],0.8578646586644072,0,0,1
231,Leptin signaling pathway WP2034,0.7958503459898717,0.6341199393808183,0.14479755849482018,['BAD'],0.8578646586644072,0,0,1
232,Spinal Cord Injury WP2431,0.8152014244159214,0.5954850518608907,0.12166953542418422,['MBP'],0.8674579259810445,0,0,1
233,Integrin-mediated Cell Adhesion WP185,0.8152014244159214,0.5954850518608907,0.12166953542418422,['ITGB5'],0.8674579259810445,0,0,1
234,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8152014244159214,0.5954850518608907,0.12166953542418422,['UBE2J1'],0.8674579259810445,0,0,1
235,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8241800232951516,0.5778720884326886,0.11174098649362503,['PPARGC1B'],0.8732801097893309,0,0,1
236,DNA damage response (only ATM dependent) WP710,0.8327237726667736,0.5612655800575264,0.10274151506279251,['BAD'],0.8782541200102733,0,0,1
237,Focal Adhesion WP306,0.835928620250742,0.6128998316498316,0.10983903651140126,"['ITGB5', 'BAD']",0.8782541200102733,0,0,2
238,TGF-beta Signaling Pathway WP366,0.8559508531200616,0.5166902154715648,0.08036719435421366,['ATF2'],0.8880490101120639,0,0,1
239,Genes related to primary cilium development (based on CRISPR) WP4536,0.8559508531200616,0.5166902154715648,0.08036719435421366,['WDR34'],0.8880490101120639,0,0,1
240,Pathways in clear cell renal cell carcinoma WP4018,0.8559508531200616,0.5166902154715648,0.08036719435421366,['DEPTOR'],0.8880490101120639,0,0,1
241,Pyrimidine metabolism WP4022,0.8759619824274577,0.47863807497135374,0.06338727900434014,['POLR1B'],0.9037739735361434,0,0,1
242,Adipogenesis WP236,0.8819962874268387,0.4671620325982742,0.058660336878442694,['NAMPT'],0.9037739735361434,0,0,1
243,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8819962874268387,0.4671620325982742,0.058660336878442694,['SESN3'],0.9037739735361434,0,0,1
244,NRF2 pathway WP2884,0.8983993068076062,0.43579418344519016,0.04669127083576916,['SLC39A11'],0.9168091286684177,0,0,1
245,Chemokine signaling pathway WP3929,0.9080512063975201,0.41710695416250176,0.040231845738480376,['GRK4'],0.9228765322162551,0,0,1
246,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9283680833318602,0.3766778523489933,0.027997328447046346,['PPARGC1B'],0.9396896453237121,0,0,1
247,mRNA Processing WP411,0.956553128930585,0.3153821173414159,0.014008941397257392,['HNRNPA2B1'],0.96429849839561,0,0,1
248,Circadian rhythm related genes WP3594,0.9606915498999278,0.3054215604026846,0.012247981629265851,['NAMPT'],0.9645653061495244,0,0,1
249,Nuclear Receptors Meta-Pathway WP2882,0.9921112386318602,0.2024958053691275,0.001603775337292769,['SLC39A11'],0.9921112386318602,0,0,1
